Definitive Healthcare (DH) sees Goldman Sachs report 5.7% stake
Rhea-AI Filing Summary
Goldman Sachs Group and Goldman Sachs & Co. LLC report beneficial ownership of 5,935,933 shares of Definitive Healthcare Corp Class A common stock, representing 5.7% of the class as of 12/31/2025.
They report shared voting power over 5,934,807 shares and shared dispositive power over 5,935,933 shares. The firms state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Definitive Healthcare.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake in Definitive Healthcare (DH) does Goldman Sachs report?
Goldman Sachs Group and Goldman Sachs & Co. LLC report beneficial ownership of 5,935,933 Class A shares of Definitive Healthcare, representing 5.7% of the class as of 12/31/2025, according to the Schedule 13G/A filing.
Who are the reporting persons in the Definitive Healthcare (DH) Schedule 13G/A?
The reporting persons are The Goldman Sachs Group, Inc., a Delaware corporation, and Goldman Sachs & Co. LLC, a New York limited liability company. Goldman Sachs & Co. LLC is a subsidiary of The Goldman Sachs Group, Inc. and a registered broker-dealer and investment adviser.
What does the Schedule 13G/A say about Goldman Sachs’ control intentions for DH?
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Definitive Healthcare, nor in connection with any transaction having that control-changing purpose or effect.
Why is The Goldman Sachs Group, Inc. included as a reporting person for DH?
The Goldman Sachs Group, Inc. is included as a parent holding company. The filing explains that the securities are owned, or may be deemed beneficially owned, by its subsidiary Goldman Sachs & Co. LLC, which is a registered broker-dealer and investment adviser.